A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Cited by (1,000)

Items 101–200 of 1,000

1. The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
   Jiaming Zhang, Xiaoping Li, Jia‐Da Li · 2019 · Frontiers in Neuroscience
2. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment
   Poehler, Anne-Maria, Xiang, Wei, Spitzer, Philipp, May, Verena Elisabeth Luise, Meixner, Holger, Rockenstein, Edward, Chutna, Oldriska, Outeiro, Tiago Fleming, Winkler, Juergen, Masliah, Eliezer et al. · 2014 · Autophagy
3. The Bacterial Curli System Possesses a Potent and Selective Inhibitor of Amyloid Formation
   Margery L. Evans, Erik Chorell, Jonathan D. Taylor, Jörgen Ådén, Anna Götheson, Fei Li, Marion Koch, Lea Sefer, Stephen Matthews, Pernilla E. Wittung-Stafshede et al. · 2015 · Molecular Cell
4. A short motif in the N-terminal region of α-synuclein is critical for both aggregation and function
   Ciaran P. A. Doherty, Sabine M. Ulamec, Roberto Maya‐Martinez, Sarah C. Good, Jemma Makepeace, G. Nasir Khan, Patricija van Oosten‐Hawle, Sheena E. Radford, David J. Brockwell · 2020 · Nature Structural & Molecular Biology
5. Prediction of "hot spots" of aggregation in disease-linked polypeptides
   Natalia Sánchez de Groot, Irantzu Pallarès, Francesc Xavier Avilés, Josep Vendrell, Salvador Ventura · 2005 · BMC Structural Biology
6. Structure and properties of α-synuclein and other amyloids determined at the amino acid level
   Charyl Del Mar, Eric A. Greenbaum, Leland C. Mayne, S. Walter Englander, Virgil L. Woods · 2005 · Proceedings of the National Academy of Sciences
7. α-Synuclein: Normal Function and Role in Neurodegenerative Diseases
   Erin H. Norris, Benoit I. Giasson, Virginia M.‐Y. Lee · 2004 · Current topics in developmental biology/Current Topics in Developmental Biology
8. Disease-specific tau filaments assemble via polymorphic intermediates
   Sofia Lövestam, David Li, Jane L. Wagstaff, Abhay Kotecha, Dari Kimanius, Stephen H. McLaughlin, Alexey G. Murzin, Stefan M.V. Freund, Michel Goedert, Sjors H. W. Scheres · 2023 · Nature
9. Mechanisms of Suppression of α-Synuclein Neurotoxicity by Geldanamycin in Drosophila
   Pavan Kumar Auluck, Marc C. Meulener, Nancy M. Bonini · 2004 · Journal of Biological Chemistry
10. M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?
    Mark S. Moehle, Andrew B. West · 2014 · Neuroscience
11. Protein Aggregation and Protein Instability Govern Familial Amyotrophic Lateral Sclerosis Patient Survival
    Qi Wang, Joshua L. Johnson, Nathalie Y.R. Agar, Jeffrey N. Agar · 2008 · PLoS Biology
12. Cellular Polyamines Promote the Aggregation of α-Synuclein
    Thomas Antony, Wolfgang Hoyer, Dmitry Cherny, Gudrun Heim, Thomas M. Jovin, Vinod Subramaniam · 2003 · Journal of Biological Chemistry
13. Determination of the Free Energy Landscape of α-Synuclein Using Spin Label Nuclear Magnetic Resonance Measurements
    Jane R. Allison, Péter Várnai, Christopher Martin Dobson, Michele Vendruscolo · 2009 · Journal of the American Chemical Society
14. p25α Stimulates α-Synuclein Aggregation and Is Co-localized with Aggregated α-Synuclein in α-Synucleinopathies
    Evo Lindersson, Ditte M. S. Lundvig, C. E. Lund Petersen, Peder Madsen, Jens Randel Nyengaard, Peter Højrup, Torben Moos, Daniel E. Otzen, Wei-Ping Gai, Peter Charles Blumbergs et al. · 2004 · Journal of Biological Chemistry
15. SDS-Induced Fibrillation of α-Synuclein: An Alternative Fibrillation Pathway
    Lise Giehm, Cristiano L. P. Oliveira, Gunna Christiansen, Jan Skov Pedersen, Daniel E. Otzen · 2010 · Journal of Molecular Biology
16. Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
    Elisa A. Waxman, Benoit I. Giasson · 2011 · Journal of Neuroscience
17. Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
    Luk, Kelvin C., Covell, Dustin J., Kehm, Victoria M., Zhang, Bin, Song, Insung Y., Byrne, Matthew D., Pitkin, Rose M., Decker, Samantha C., Trojanowski, John Q., Lee, Virginia M.-Y. · 2016 · Cell Reports
18. Interactions Among α-Synuclein, Dopamine, and Biomembranes: Some Clues for Understanding Neurodegeneration in Parkinson's Disease
    Jean‐Christophe Rochet, Tiago F. Outeiro, Kelly A. Conway, Tomas T. Ding, Michael J. Volles, Hilal Ahmed Lashuel, Robert M. Bieganski, Susan Lee Lindquist, Peter T. Lansbury · 2004 · Journal of Molecular Neuroscience
19. Biophysics of α-synuclein membrane interactions
    Candace M. Pfefferkorn, Zhiping Jiang, Jennifer C. Lee · 2011 · Biochimica et Biophysica Acta (BBA) - Biomembranes
20. A strategy for designing inhibitors of α ‐synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders
    Omar M. A. El‐Agnaf, Katerina E. Paleologou, Brett Greer, Abdulmawala M. Abogrein, Jenny E. King, Sultan A. Salem, Nigel J. Fullwood, Fiona E. Benson, Rebecca Hewitt, Kirstie J. Ford et al. · 2004 · The FASEB Journal
21. Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes
    Rannikko, Emmy H., Weber, Stephanie S., Kahle, Philipp J. · 2015 · BMC Neuroscience
22. More than just two peas in a pod: common amyloidogenic properties of tau and α-synuclein in neurodegenerative diseases
    Virginia M.‐Y. Lee, Benoit I. Giasson, John Q. Trojanowski · 2004 · Trends in Neurosciences
23. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
    Victorio M. Pozo Devoto, Tomás Luis Falzone · 2017 · Disease Models & Mechanisms
24. Effects of Oxidative and Nitrative Challenges on α-Synuclein Fibrillogenesis Involve Distinct Mechanisms of Protein Modifications
    Erin H. Norris, Benoit I. Giasson, Harry Ischiropoulos, Virginia M.‐Y. Lee · 2003 · Journal of Biological Chemistry
25. Strategies to increase the reproducibility of protein fibrillization in plate reader assays
    Lise Giehm, Daniel E. Otzen · 2010 · Analytical Biochemistry
26. Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
    Jacqueline Burré, Manu Sharma, Thomas Christian Südhof · 2012 · Journal of Neuroscience
27. Monoubiquitylation of α-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells
    Ruth Rott, Raymonde Szargel, Joseph Haskin, Vered Shani, Alla Shainskaya, Irena Manov, Esti Liani, Eyal Avraham, Simone Engelender · 2007 · Journal of Biological Chemistry
28. The emerging role of α-synuclein truncation in aggregation and disease
    Zachary A. Sorrentino, Benoit I. Giasson · 2020 · Journal of Biological Chemistry
29. Site-Specific Interactions of Cu(II) with α and β-Synuclein: Bridging the Molecular Gap between Metal Binding and Aggregation
    Andrés Binolfi, Gonzalo R. Lamberto, Rosario Durán, Liliana Quintanar, Carlos W. Bertoncini, José M. Souza, Carlos Červeñanský, Markus Zweckstetter, Christian Griesinger, Claudio O. Fernández · 2008 · Journal of the American Chemical Society
30. Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons
    Romi Anirban Saha, Josephine E. Hill, Michelle A. Utton, Ayodeji A. Asuni, Steven Ackerley, Andrew J. Grierson, Christopher C.J. Miller, Alun Milward Davies, Vladimir L. Buchman, Brian H. Anderton et al. · 2004 · Journal of Cell Science
31. Is Parkinson’s disease a lysosomal disorder?
    Andrés D. Klein, Joseph R. Mazzulli · 2018 · Brain
32. Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
    Rita Perfeito, Teresa Cunha‐Oliveira, Ana Cristina Rego · 2013 · Free Radical Biology and Medicine
33. Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies
    Richard J. Karpowicz, Conor M. Haney, Tiberiu S. Mihaila, Raizel M. Frasier, E. James Petersson, Virginia M.‐Y. Lee · 2017 · Journal of Biological Chemistry
34. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
    Chao Peng, Ronald J. Gathagan, Virginia M.‐Y. Lee · 2017 · Neurobiology of Disease
35. Does α‐synuclein modulate dopaminergic synaptic content and tone at the synapse?
    Anita Sidhu, Christophe Wersinger, Philippe Vernier · 2004 · The FASEB Journal
36. α-Synuclein and the Lewy body disorders
    Dennis W. Dickson · 2001 · Current Opinion in Neurology
37. Distinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro
    Amanda J. Mishizen-Eberz, Rodney P. Guttmann, Benoit I. Giasson, George A. Day, Roberto Hodara, Harry Ischiropoulos, Virginia M.‐Y. Lee, John Q. Trojanowski, David R. Lynch · 2003 · Journal of Neurochemistry
38. β-Synuclein Inhibits Formation of α-Synuclein Protofibrils: A Possible Therapeutic Strategy against Parkinson's Disease
    June-Young Park, Peter T. Lansbury · 2003 · Biochemistry
39. α-Synuclein–induced Aggregation of Cytoplasmic Vesicles inSaccharomyces cerevisiae
    James H. Soper, Subhojit Roy, Anna Stieber, Eliza Lee, Robert B. Wilson, John Q. Trojanowski, Christopher G. Burd, Virginia M.‐Y. Lee · 2008 · Molecular Biology of the Cell
40. Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
    Amberley D. Stephens, Maria Zacharopoulou, Rani Moons, Giuliana Fusco, Neeleema Seetaloo, Anass Chiki, Philippa J. Woodhams, Ioanna Mela, Hilal Ahmed Lashuel, Jonathan J. Phillips et al. · 2020 · Nature Communications
41. A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
    Silke Nuber, Florian Harmuth, Zacharias Kohl, Anthony Adame, Margaritha Trejo, Kai Schönig, Frank Zimmermann, Claudia C. Bauer, Nicolas Casadei, Christiane Giel et al. · 2013 · Brain
42. Comparison of Structure and Dynamics of Micelle-bound Human α-Synuclein and Parkinson Disease Variants
    Tobias S. Ulmer, Ad Bax · 2005 · Journal of Biological Chemistry
43. A Peptide Motif Consisting of Glycine, Alanine, and Valine Is Required for the Fibrillization and Cytotoxicity of Human α-Synuclein
    Hai‐Ning Du, Lin Tang, Xiaoying Luo, Hongtao Li, Jun Hu, Jiawei Zhou, Hong‐Yu Hu · 2003 · Biochemistry
44. Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced Toxicity
    Sharareh Emadi, Hedieh Barkhordarian, Min S. Wang, Philip Schulz, Michael R. Sierks · 2007 · Journal of Molecular Biology
45. Structured Regions of α-Synuclein Fibrils Include the Early-Onset Parkinson's Disease Mutation Sites
    Gemma Comellas, Luisel Lemkau, Andrew J. Nieuwkoop, Kathryn D. Kloepper, Daniel T. Ladror, Reika Ebisu, Wendy S. Woods, Andrew S. Lipton, Julia M. George, Chad M. Rienstra · 2011 · Journal of Molecular Biology
46. Modulating α-Synuclein Liquid–Liquid Phase Separation
    Ajay Singh Sawner, Soumik Ray, Preeti Yadav, Semanti Mukherjee, Rajlaxmi Panigrahi, Manisha Poudyal, Komal Patel, Dhiman Ghosh, Eric Kummerant, Ashutosh Kumar et al. · 2021 · Biochemistry
47. Identification of the region of non‐Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity
    Angela M. Bodles, David J. S. Guthrie, Brett Greer, G. Brent Irvine · 2001 · Journal of Neurochemistry
48. Amyloid-forming Peptides from β2-Microglobulin—Insights into the Mechanism of Fibril Formation in Vitro
    Susan Jones, James Manning, Neil M. Kad, Sheena E. Radford · 2002 · Journal of Molecular Biology
49. Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells
    Andis Klegeris, Benoit I. Giasson, Hong Zhang, John A. Maguire, Steven Pelech, Patrick L. McGeer · 2006 · The FASEB Journal
50. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy
    Rachael H. Earls, Kelly B. Menees, Jaegwon Chung, Claire‐Anne Gutekunst, Hyun Joon Lee, Manuel G. Hazim, Balázs Rada, Levi Benjamin Wood, Jae‐Kyung Lee · 2020 · Proceedings of the National Academy of Sciences
51. Helix periodicity, topology, and dynamics of membrane‐associated α‐Synuclein
    Robert Bussell, Trudy F. Ramlall, David Eliezer · 2005 · Protein Science
52. Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker
    Sacino, Amanda N., Brooks, Mieu, McKinney, Alex B., Thomas, Michael A., Shaw, Gerry, Golde, Todd E., Giasson, Benoit I. · 2014 · The Journal of Neuroscience
53. Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?
    Andrés Binolfi, François‐Xavier Theillet, Philipp Selenko · 2012 · Biochemical Society Transactions
54. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle
    Kristen A. Malkus, Elpida Tsika, Harry Ischiropoulos · 2009 · Molecular Neurodegeneration
55. Lipid-Chaperone Hypothesis: A Common Molecular Mechanism of Membrane Disruption by Intrinsically Disordered Proteins
    Michele F. M. Sciacca, Fabio Lolicato, Carmelo Tempra, Federica Scollo, Bikash Ranjan Sahoo, Matthew D. Watson, Sara García‐Viñuales, Danilo Milardi, Antonio Raudino, Jennifer C. Lee et al. · 2020 · ACS Chemical Neuroscience
56. Structural insights on physiological functions and pathological effects of ±‐synuclein
    Marco Bisaglia, Stefano Mammi, Luigi Bubacco · 2008 · The FASEB Journal
57. α-Synuclein Affects the MAPK Pathway and Accelerates Cell Death
    Atsushi Iwata, Mieko Maruyama, Ichiro Kanazawa, Nobuyuki Nukina · 2001 · Journal of Biological Chemistry
58. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
    Earls, Rachael H., Menees, Kelly B., Chung, Jaegwon, Barber, James, Gutekunst, Claire-Anne, Hazim, Manuel G., Lee, Jae-Kyung · 2019 · Journal of Neuroinflammation
59. Unique copper‐induced oligomers mediate alpha‐synuclein toxicity
    Josephine A. Wright, Xiaoyan Wang, David R. Brown · 2009 · The FASEB Journal
60. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114
    Adam Crystal, Benoit I. Giasson, Alex Crowe, Mei‐Ping Kung, Zhi‐Ping Zhuang, John Q. Trojanowski, Virginia M.‐Y. Lee · 2003 · Journal of Neurochemistry
61. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
    Brás, Inês C., Outeiro, Tiago F. · 2021 · Cells
62. Ubiquitination of α-Synuclein Is Not Required for Formation of Pathological Inclusions in α-Synucleinopathies
    Deepak M. Sampathu, Benoit I. Giasson, Aaron C. Pawlyk, John Q. Trojanowski, Virginia M.‐Y. Lee · 2003 · American Journal Of Pathology
63. Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer′s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies
    Patrick Oeckl, Fabian Metzger, Magdalena Nagl, Christine A. F. Von Arnim, Steffen Halbgebauer, Petra Steinacker, Albert Christian Ludolph, Markus Otto · 2016 · Molecular & Cellular Proteomics
64. The Emerging Role of the Lysosome in Parkinson’s Disease
    Alba Navarro-Romero, Marta Montpeyó, Marta Martínez‐Vicente · 2020 · Cells
65. Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration
    Katrin Beyer, Aurelio Ariza · 2012 · Molecular Neurobiology
66. Structural Intermediates during α-Synuclein Fibrillogenesis on Phospholipid Vesicles
    Gemma Comellas, Luisel Lemkau, Donghua H. Zhou, Julia M. George, Chad M. Rienstra · 2012 · Journal of the American Chemical Society
67. E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment
    Kristel L. Emmer, Elisa A. Waxman, Jason P. Covy, Benoit I. Giasson · 2011 · Journal of Biological Chemistry
68. Bioinorganic chemistry of copper coordination to alpha-synuclein: Relevance to Parkinson's disease
    Andrés Binolfi, Liliana Quintanar, Carlos W. Bertoncini, Christian Griesinger, Claudio O. Fernández · 2012 · Coordination Chemistry Reviews
69. Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson’s Disease
    Yan Xu, Yanyan Zhang, Zhenzhen Quan, Winnie Wong, Jian‐Ping Guo, Rongkai Zhang, Qinghu Yang, Rongji Dai, Patrick L. McGeer, Hong Qing · 2016 · Neurochemical Research
70. The Close Encounter Between Alpha-Synuclein and Mitochondria
    Mattia Vicario, Domenico Cieri, Marisa Brini, Tito Calí · 2018 · Frontiers in Neuroscience
71. Structural insights into α-synuclein monomer–fibril interactions
    Pratibha Kumari, Dhiman Ghosh, Agathe Vanas, Yanick Fleischmann, Thomas Wiegand, Gunnar Jeschke, Roland Riek, Cédric Eichmann · 2021 · Proceedings of the National Academy of Sciences
72. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α‐synuclein
    Nicola J. Rutherford, Brenda D. Moore, Todd Eliot Golde, Benoit I. Giasson · 2014 · Journal of Neurochemistry
73. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis
    Semanti Mukherjee, Arunima Sakunthala, Laxmikant G. Gadhe, Manisha Poudyal, Ajay Singh Sawner, Pradeep Kadu, Samir Kumar Maji · 2022 · Journal of Molecular Biology
74. Bioinorganic Chemistry of Parkinson’s Disease: Structural Determinants for the Copper-Mediated Amyloid Formation of Alpha-Synuclein
    Andrés Binolfi, Esaú E. Rodríguez, Daniela Valensin, Nicola D’Amelio, Emiliano Ippoliti, Gonzalo Obal, Rosario Durán, Alessandra Magistrato, Otto Pritsch, Markus Zweckstetter et al. · 2010 · Inorganic Chemistry
75. Interactions between Hsp70 and the Hydrophobic Core of α-Synuclein Inhibit Fibril Assembly
    Kelvin C. Luk, Ian P. Mills, John Q. Trojanowski, Virginia M.‐Y. Lee · 2008 · Biochemistry
76. Sequestration of a β‐Hairpin for Control of α‐Synuclein Aggregation
    Ewa A. Mirecka, Hamed Shaykhalishahi, Aziz Gauhar, Şerife Akgül, Justin Lecher, Dieter Willbold, Matthias Stoldt, Wolfgang Hoyer · 2014 · Angewandte Chemie International Edition
77. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production
    Tapias, Victor, Hu, Xiaoping, Luk, Kelvin C., Sanders, Laurie H., Lee, Virginia M., Greenamyre, J. Timothy · 2017 · Cellular and Molecular Life Sciences
78. The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
    Asad Jan, Nádia Pereira Gonçalves, Christian Bjerggaard Vægter, Poul Henning Jensen, Nelson Ferreira · 2021 · International Journal of Molecular Sciences
79. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
    Roberta Cascella, Alessandra Bigi, Nunilo Cremades, Cristina Cecchi · 2022 · Cellular and Molecular Life Sciences
80. Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α‐synuclein complex by Hip
    Cintia Roodveldt, Carlos W. Bertoncini, August Andersson, Annemieke T. van der Goot, Shang‐Te Danny Hsu, Rafael Fernández-Montesinos, Jannie de Jong, Tjakko J. van Ham, Ellen A. A. Nollen, David Pozo et al. · 2009 · The EMBO Journal
81. Many Overlapping Peptides for Protein Hydrogen Exchange Experiments by the Fragment Separation-Mass Spectrometry Method
    Leland C. Mayne, Zhong-Yuan Kan, Palaniappan Sevugan Chetty, Alec Ricciuti, Benjamin T. Walters, S. Walter Englander · 2011 · Journal of the American Society for Mass Spectrometry
82. Neurodegeneration and the ordered assembly of α-synuclein
    Maria Grazia Spillantini, Michel Goedert · 2017 · Cell and Tissue Research
83. Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
    Choi, Dong-Hee, Kim, Youn-Jung, Kim, Young-Gun, Joh, Tong H., Beal, M. Flint, Kim, Yoon-Seong · 2011 · Journal of Biological Chemistry
84. Small-molecule PET Tracers for Imaging Proteinopathies
    Chester A. Mathis, Brian J. Lopresti, Miloš D. Ikonomović, William Edward Klunk · 2017 · Seminars in Nuclear Medicine
85. ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
    Wouter Peelaerts, Luc Bousset, Veerle Baekelandt, Ronald Melki · 2018 · Cell and Tissue Research
86. Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats
    Nathalie Van Den Berge, Nelson Ferreira, Trine Werenberg Mikkelsen, Aage Kristian Olsen Alstrup, Gültekin Tamgüney, Páll Karlsson, Astrid Juhl Terkelsen, Jens Randel Nyengaard, Poul Henning Jensen, Per Borghammer · 2021 · Brain
87. Initiation and progression of α-synuclein pathology in Parkinson’s disease
    George K. Tofaris · 2022 · Cellular and Molecular Life Sciences
88. Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase
    Francesco Bemporad, Niccolò Taddei, Massimo Stefani, Fabrizio Chiti · 2006 · Protein Science
89. Molecular Pathology of Lewy Body Diseases
    Katrin Beyer, Montserrat Domingo-Sàbat, Aurelio Ariza · 2009 · International Journal of Molecular Sciences
90. Genetics of Parkinson's disease and biochemical studies of implicated gene products
    Peter T. Lansbury, Alexis Brice · 2002 · Current Opinion in Genetics & Development
91. Chapter 6 Molecular and Cellular Biology of Synucleins
    Andrei P. Surguchov · 2008 · International review of cytology
92. Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease
    Abid Oueslati, Katerina E. Paleologou, Bernard Laurent Schneider, Patrick Aebischer, Hilal Ahmed Lashuel · 2012 · Journal of Neuroscience
93. Structural Characteristics of α-Synuclein Oligomers
    Nunilo Cremades, Serene W. Chen, Christopher Martin Dobson · 2016 · International review of cytology
94. Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
    Eftychia Vasili, Antonio Dominguez‐Meijide, Tiago F. Outeiro · 2019 · Frontiers in Molecular Neuroscience
95. Cleavage of α-Synuclein by Calpain: Potential Role in Degradation of Fibrillized and Nitrated Species of α-Synuclein
    Amanda J. Mishizen-Eberz, Erin H. Norris, Benoit I. Giasson, Roberto Hodara, Harry Ischiropoulos, Virginia M.‐Y. Lee, John Q. Trojanowski, David R. Lynch · 2005 · Biochemistry
96. Metal-catalyzed Oxidation of α-Synuclein
    Nelson B. Cole, Diane D. Murphy, Jacob Lebowitz, Luca Di Noto, Rodney L. Levine, Robert Luke Nussbaum · 2004 · Journal of Biological Chemistry
97. An scFv Intrabody against the Nonamyloid Component of α-Synuclein Reduces Intracellular Aggregation and Toxicity
    Sandra M. Lynch, Chun Zhou, Anne C. Messer · 2007 · Journal of Molecular Biology
98. Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases
    Caterina Migliorini, Elena Porciatti, Marek Łuczkowski, Daniela Valensin · 2011 · Coordination Chemistry Reviews
99. Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts
    Špela Korat, Natasha Bidesi, Federica Bonanno, Adriana Di Nanni, Anh Nguyên Nhât Hoàng, Kristina Herfert, Andreas Maurer, Umberto Maria Battisti, Gregory D. Bowden, David Thonon et al. · 2021 · Pharmaceuticals
100. Proteotoxic stress and the ubiquitin proteasome system
     Rachel Kandel, Jasmine Jung, Sonya E. Neal · 2023 · Seminars in Cell and Developmental Biology